TLPH
Talphera, Inc.
There isn't enough reported data to score TLPH yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
TLPH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
TLPH's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
TLPH PE Valuation
TLPH has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
TLPH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect TLPH's losses to shrink, with revenue holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
TLPH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.24 | +$0.13 |
| Q2 2026 | -$0.30 | +$0.09 |
| Q1 2026 | -$0.34 | +$0.10 |
| Q4 2025 | -$0.40 | +$0.10 |
| Q3 2025 | -$0.37 | +$0.34 |
| Q2 2025 | -$0.39 | +$0.27 |
| Q1 2025 | -$0.44 | +$0.47 |
| Q4 2024 | -$0.50 | +$1.00 |
TLPH is still losing money, but far less than before: $0.24 per share over the past year, against $14.00 at its worst in early 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over TLPH on earnings quality, reporting a profit while its opponent remains loss making.
TLPH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $281K | +12% |
| Q3 2023 | $117K | -77% |
| Q2 2023 | $253K | -56% |
| Q4 2022 | $252K | +12500% |
| Q3 2022 | $507K | -73% |
| Q2 2022 | $570K | +29% |
| Q1 2022 | $442K | -14% |
| Q4 2021 | $2K | -100% |
TLPH's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -342200% | N/A |
| Q1 2025 | -10800% | N/A |
| Q4 2023 | -1524% | +1425 points |
| Q3 2023 | -2828% | -1520 points |
| Q2 2023 | -1569% | +813 points |
| Q4 2022 | -2950% | +405800 points |
| Q3 2022 | -1308% | -844 points |
| Q2 2022 | -2381% | -121 points |
TLPH's operating margin was −342200% last quarter, down 340631 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over TLPH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
TLPH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -$524K |
| Q2 2026 | -$3.9M | -$976K |
| Q1 2026 | -$3.4M | +$70K |
| Q4 2025 | -$2.4M | -$182K |
| Q3 2025 | -$2.5M | +$426K |
| Q2 2025 | -$2.9M | +$1.7M |
| Q1 2025 | -$3.5M | -$587K |
| Q4 2024 | -$2.3M | +$1.7M |
TLPH has burned cash in almost every quarter: −$13M over the past year, against −$11M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over TLPH on cash generation, producing positive trailing cash flow while its opponent burns cash.
TLPH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +17.1K shares |
| 1 year | +82% | +34.1M shares |
| 3 years | +592% | +64.6M shares |
| 5 years | +1234% | +69.9M shares |
| Available history | +1808% | +71.6M shares |
TLPH has 76M diluted shares, up 82% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over TLPH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
TLPH Net Leverage
TLPH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
TLPH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.1 | Neutral |
| Stochastic | 5.7 | Oversold |
TLPH's weekly RSI is 46 (neutral) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
TLPH PE vs Healthcare Sector
| Metric | TLPH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
TLPH has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
TLPH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 4.6% below |
| 20 week MA | $1.19 | 13% below |
| 50 week MA | $1.03 | 0% above |
| 100 week MA | $0.85 | 21% above |
| 200 week MA | $0.91 | 13% above |
TLPH has slipped below its 8-, 20- and 50-week averages, though it's still 13% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over TLPH on trend strength, trading above more of its moving averages.
TLPH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.8 | $25.4 | -43% |
| 2021 | $25.4 | $11.2 | -56% |
| 2022 | $11.2 | $2.07 | -82% |
| 2023 | $2.07 | $0.74 | -64% |
| 2024 | $0.74 | $0.53 | -28% |
| 2025 | $0.53 | $1.10 | +108% |
| 2026 YTD | $1.10 | $1.03 | -6.4% |
TLPH's yearly returns have swung widely, from +108% in 2025 to −82% in 2022. It's down 6.4% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over TLPH on returns for 2026, with the stronger performance.